Cva Family Office, LLC Cooper Companies, Inc. Transaction History

Cva Family Office, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 16, 2024	BUY	$306.88 - $380.0 $7,672 - $9,500	25 New	25 $9,000
Q2 2023 Jul 10, 2023	BUY	$346.15 - $392.09 $7,961 - $9,018	23 Added 76.67%	53 $20,000
Q1 2023 Apr 26, 2023	BUY	$323.56 - $373.36 $1,617 - $1,866	5 Added 20.0%	30 $11,000
Q4 2022 Feb 21, 2023	BUY	$248.67 - $334.17 $2,486 - $3,341	10 Added 66.67%	25 $8,000
Q3 2022 Nov 22, 2022	SELL	$263.81 - $337.27 $15,828 - $20,236	-60 Reduced 80.0%	15 $4,000
Q2 2022 Jul 11, 2022	BUY	$301.4 - $428.42 $21,098 - $29,989	70 Added 1400.0%	75 $23,000
Q4 2021 Jan 25, 2022	BUY	$373.53 - $434.12 $1,867 - $2,170	5 New	5 $2,000
Q3 2021 Oct 12, 2021	SELL	$396.76 - $455.92 $1,983 - $2,279	-5 Closed	0 $0
Q2 2021 Jul 13, 2021	SELL	$372.36 - $412.07 $8,936 - $9,889	-24 Reduced 82.76%	5 $2,000
Q1 2021 Apr 14, 2021	BUY	$357.26 - $392.57 $10,360 - $11,384	29 New	29 $11,000

1.59M

Ticker COO
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 49,346,000
Market Cap $4.92B
Description
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...

Get notified when there are updates to the investment portfolio of Cva Family Office, LLC, based on Form 13F filings with the SEC.

Stay updated on Cva Family Office, LLC with notifications on news.